MAZE
NASDAQ · Pharmaceuticals
Maze Therapeutics Inc
$27.17
+0.59 (+2.22%)
Performance
1D
—
1W
—
1M
—
3M
-43.05%
6M
-15.78%
1Y
+168.21%
YTD
-31.68%
Open$26.53
Previous Close$26.58
Day High$27.58
Day Low$26.24
52W High$53.65
52W Low$8.25
Volume—
Avg Volume565.6K
Market Cap1.41B
P/E Ratio—
EPS$-2.07
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$42.71
Below
SMA 200
$25.83
Above
RSI (14)
50.1
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
12 analysts
Price Target
+245.6% upside
Current
$27.17
$27.17
Target
$93.90
$93.90
$74.59
$93.90 avg
$145.81
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 190.13M | 546.10M | 525.77M |
| Net Income | 20.86M | 109.70M | 88.79M |
| Profit Margin | 11.0% | 20.1% | 16.9% |
| EBITDA | 69.11M | 173.82M | 160.69M |
| Free Cash Flow | — | 65.89M | 67.30M |
| Rev Growth | — | +21.9% | +7.3% |
| Debt/Equity | — | 0.74 | 0.66 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |